You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
三連板亞寶藥業(600351.SH)提示風險:公司股票市盈率遠高於同行業平均水平
格隆匯 08-05 19:36

格隆匯 8 月 5日丨亞寶藥業(600351.SH)公佈,公司股票於2020年7月31日、8月3日、8月4日連續三個交易日內日收盤價格漲幅偏離值累計超過20%,根據《上海證券交易所交易規則》的有關規定,屬於股票交易異常波動情形。2020年8月5日公司股票收盤價格繼續上漲9.96%。鑑於近期公司股票價格波動較大,現將風險提示如下:

一、經營業績風險

公司主營業務未發生重大變化,公司2020年第一季度業績同比下滑明顯,公司2020年第一季度實現營業收入約6.24億元,比上年同期減少24.09%;歸屬於上市公司股東的淨利潤3998.58萬元,比上年同期減少46.83%;歸屬於上市公司股東的扣除非經常性損益的淨利潤3454.31萬元,比上年同期減少52.35%(上述財務數據未經審計),特別提醒投資者注意經營業績風險。

二、公司股票市盈率遠高於同行業平均水平

截止2020年8月5日,公司靜態市盈率為421.90,滾動市盈率為-275.41;根據同日中證指數有限公司提供的證監會行業市盈率數據,公司所在醫藥製造業最新行業平均靜態市盈率為60.8,滾動市盈率為61.89。公司股票市盈率遠高於同行業平均水平,特別提醒投資者注意二級市場交易風險。

三、股東減持風險

2020年7月14日,公司發佈《亞寶藥業集團股份有限公司股東集中競價減持股份計劃公告》(公告編號:2020-029),控股股東山西亞寶投資集團有限公司計劃通過集中競價方式在2020年8月5日至2021年2月1日期間減持公司股份不超過1540萬股,特別提醒投資者注意股東減持風險。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account